Biotechnology – DNB CET Study Notes
(Biology – 2026 DNB CET)
1. Simple Explanation
Biotechnology is the use of living organisms, cells, and biomolecules to create useful products or solve practical problems. It combines biology, chemistry, physics, and engineering to manipulate genetic material for medicine, agriculture, industry, and the environment.
Key takeaway: Biotechnology is technology based on biological systems, living organisms, or derivatives thereof.
2. Key Points (Quick Reference)
| # | Concept | Why It Matters |
|---|---|---|
| 1 | Types – Traditional, Modern (Molecular, Cell, Microbial, Plant, Environmental) | Different tools & applications |
| 2 | Molecular Tools – plasmids, vectors, restriction enzymes, ligase, PCR, CRISPR | Core techniques in genetic manipulation |
| 3 | Modern Techniques – recombinant DNA, gene editing, transgenics, synthetic biology | Drive current innovations |
| 4 | Applications – Medicine (vaccines, gene therapy), Agriculture (GM crops, tissue culture), Environment (bioremediation) | Real‑world impact |
| 5 | Ethical/Law – GMOs, gene patents, clonal selection | Responsible use & policy |
| 6 | Future Trends – CRISPR‑Cas9, gene drives, personalized medicine, bio‑fabrication | Where science is heading |
3. Detailed Overview
3.1 Definition & Scope
- Biotechnology: Manipulation of biological systems (organisms, cells, biomolecules) to produce products or services.
- Scope:
- Molecular – recombinant DNA, gene cloning, PCR.
- Cellular – cell culture, tissue engineering.
- Microbial – fermentation, enzyme production.
- Plant – GM crops, marker‑assisted breeding.
- Environmental – bioremediation, bio‑fuel production.
3.2 Historical Milestones
| Year | Milestone | Significance |
|---|---|---|
| 1973 | First recombinant DNA (Sutherland & Cohen) | Birth of modern biotech |
| 1975 | First genetically modified organism (E. coli) | Proof of concept |
| 1985 | First GMO crop (Bt cotton) | Agricultural impact |
| 1990 | Human insulin from E. coli | Pharmaceutical breakthrough |
| 2012 | CRISPR‑Cas9 editing | Precise, efficient gene editing |
| 2020 | COVID‑19 mRNA vaccines | Rapid vaccine platform |
3.3 Types of Biotechnology
| Type | Description | Example |
|---|---|---|
| Traditional | Selective breeding, fermentation, natural product isolation | Milk, bread, antibiotics |
| Molecular | DNA manipulation, recombinant proteins | Recombinant insulin, gene therapy |
| Cell | Cell culture, tissue engineering | Stem‑cell derived tissues |
| Microbial | Engineered microbes for chemicals | E. coli producing bio‑ethanol |
| Plant | Transgenic crops, marker‑assisted selection | Bt maize, high‑yield rice |
| Environmental | Bioremediation, bio‑fuel | Bacteria degrading oil spills |
3.4 Modern Tools & Techniques
| Tool | Principle | Typical Use |
|---|---|---|
| Restriction Enzymes | Cut DNA at specific sequences | Gene cloning |
| Ligase | Seals DNA nicks | Joining fragments |
| Vectors (plasmids, cosmids) | Carry foreign DNA into host | Gene expression |
| PCR (Polymerase Chain Reaction) | Amplifies DNA exponentially | Diagnostics, cloning |
| RT‑PCR | Reverse transcription + PCR | Gene expression analysis |
| Southern Blot | DNA hybridization | Gene mapping |
| Northern/Western Blot | RNA/Protein detection | Expression studies |
| CRISPR‑Cas9 | RNA‑guided DNA cleavage | Gene knockout/knock‑in |
| Gene‑Worm | Whole‑genome sequencing | Genomic studies |
3.5 Applications
| Domain | Key Applications | Impact |
|---|---|---|
| Medicine | Vaccines (COVID‑19 mRNA), monoclonal antibodies, gene therapy, diagnostics (PCR) | Improved treatment, rapid detection |
| Agriculture | GM crops (Bt, herbicide tolerance), tissue culture (micropropagation), marker‑assisted breeding | Higher yield, pest resistance |
| Industry | Enzyme production, bio‑fuels, bioplastics | Sustainable manufacturing |
| Environment | Bioremediation of oil, heavy metals, waste treatment | Pollution control |
3.5.1 Medical Example – mRNA Vaccine
- mRNA encoding SARS‑CoV‑2 spike protein is encapsulated in lipid nanoparticles.
- Delivered intramuscularly → host cells translate spike protein → immune response.
- Rapid design + scalable production.
3.6 Ethical, Legal, Social Implications (ELSI)
| Issue | Concern | Regulation |
|---|---|---|
| GMOs | Ecological risk, gene flow | Cartagena Protocol, national biosafety laws |
| Gene Editing | Off‑target effects, germline editing | WHO guidelines, national legislation |
| **Pat |